How does high VLDL affect heart health?

High VLDL cholesterol contributes to atherosclerosis by depositing fat in artery walls, increasing heart disease and stroke risk. Levels above 30 mg/dL are concerning, and lifestyle changes like diet modification, exercise, and weight loss can effectively lower VLDL.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What is VLDL cholesterol?

Very low-density lipoprotein (VLDL) is one of the five major types of lipoproteins that transport cholesterol and triglycerides through your bloodstream. Think of lipoproteins as vehicles that carry fats through your blood, since fats can't dissolve in the watery environment of your bloodstream on their own.

Your liver produces VLDL particles, which are particularly rich in triglycerides—containing about 50-65% triglycerides by weight. As VLDL particles circulate through your bloodstream, they deliver triglycerides to your tissues for energy or storage. During this process, VLDL particles gradually lose their triglyceride content and transform into intermediate-density lipoprotein (IDL) and eventually into low-density lipoprotein (LDL), often called 'bad cholesterol.'

While VLDL serves an important function in transporting energy-rich triglycerides to your cells, elevated levels can significantly impact your cardiovascular health. Understanding your VLDL levels through comprehensive cholesterol testing provides crucial insights into your heart disease risk.

VLDL Cholesterol Levels and Cardiovascular Risk

VLDL Level (mg/dL)CategoryCardiovascular RiskRecommended Action
Below 20<20 mg/dLOptimalLowMaintain healthy lifestyle
20-3020-30 mg/dLNormalAverageMonitor regularly, optimize diet
31-4031-40 mg/dLBorderline HighIncreasedLifestyle modifications recommended
Above 40>40 mg/dLHighSignificantly IncreasedMedical evaluation, possible medication

VLDL levels should be evaluated alongside other lipid markers and cardiovascular risk factors for comprehensive assessment.

How VLDL contributes to heart disease

High VLDL cholesterol poses a serious threat to your cardiovascular system through multiple mechanisms. When VLDL levels remain elevated, these particles can penetrate the walls of your arteries, particularly in areas where blood flow creates turbulence or stress on the vessel walls.

The atherosclerosis connection

Once inside the arterial wall, VLDL particles undergo oxidation, triggering an inflammatory response. Your immune system sends white blood cells called macrophages to engulf these oxidized particles. However, when macrophages become overloaded with cholesterol, they transform into foam cells, which accumulate and form fatty streaks—the earliest visible sign of atherosclerosis.

Over time, these fatty deposits grow into atherosclerotic plaques that narrow your arteries and reduce blood flow. Even more concerning, these plaques can rupture, causing blood clots that may completely block blood flow to your heart (causing a heart attack) or brain (causing a stroke).

VLDL and triglyceride levels

Since VLDL particles are the primary carriers of triglycerides in your blood, high VLDL levels typically correlate with elevated triglyceride levels. High triglycerides independently increase your risk of heart disease and often occur alongside other metabolic problems like insulin resistance, obesity, and metabolic syndrome.

Research shows that for every 88 mg/dL increase in triglycerides, cardiovascular disease risk increases by approximately 22%. This relationship underscores why monitoring both VLDL and triglyceride levels is essential for comprehensive cardiovascular risk assessment.

Understanding VLDL levels and ranges

VLDL cholesterol is typically calculated rather than directly measured, using the formula: VLDL = Triglycerides ÷ 5 (when triglycerides are below 400 mg/dL). Understanding what constitutes normal versus elevated VLDL levels helps you assess your cardiovascular risk.

Most laboratories consider VLDL levels between 2-30 mg/dL as normal. However, optimal levels for cardiovascular health are generally below 20 mg/dL. Levels above 30 mg/dL are considered high and warrant attention through lifestyle modifications or medical intervention.

Factors affecting VLDL measurement

Several factors can influence your VLDL levels and the accuracy of measurements. Fasting for 9-12 hours before testing is crucial, as recent food intake can significantly elevate triglyceride and VLDL levels. Additionally, alcohol consumption, certain medications, and acute illness can temporarily affect your results.

What causes high VLDL cholesterol?

Multiple factors can contribute to elevated VLDL levels, ranging from lifestyle choices to genetic predisposition. Understanding these causes helps you identify which factors you can modify to improve your cardiovascular health.

Dietary factors

  • High intake of refined carbohydrates and added sugars, which your liver converts to triglycerides
  • Excessive alcohol consumption, which stimulates triglyceride production in the liver
  • Trans fats and excessive saturated fats, which can increase VLDL production
  • Frequent consumption of high-fructose corn syrup, particularly from sugary beverages

Metabolic and medical conditions

  • Insulin resistance and type 2 diabetes, which increase liver production of VLDL
  • Metabolic syndrome, characterized by abdominal obesity, high blood pressure, and abnormal cholesterol levels
  • Hypothyroidism, which slows the clearance of VLDL from your bloodstream
  • Kidney disease, which can impair lipid metabolism
  • Genetic disorders like familial hypertriglyceridemia

Lifestyle and other factors

Sedentary behavior significantly contributes to elevated VLDL levels by reducing your body's ability to clear triglycerides from the bloodstream. Excess body weight, particularly abdominal obesity, increases VLDL production in the liver. Certain medications, including corticosteroids, beta-blockers, and some diuretics, can also raise VLDL levels as a side effect.

Health risks beyond heart disease

While cardiovascular disease remains the primary concern with elevated VLDL, high levels can impact multiple organ systems and contribute to various health complications.

High VLDL cholesterol significantly increases your risk of pancreatitis when triglyceride levels exceed 500 mg/dL. This painful inflammation of the pancreas can be life-threatening and often requires hospitalization. Additionally, elevated VLDL contributes to non-alcoholic fatty liver disease (NAFLD), where excess fat accumulates in liver cells, potentially progressing to cirrhosis.

Research also links high VLDL to increased risk of peripheral artery disease, which reduces blood flow to your limbs and can cause pain, numbness, and in severe cases, tissue death. Some studies suggest connections between elevated VLDL and cognitive decline, though more research is needed to establish causation.

Testing and monitoring VLDL levels

Regular monitoring of your VLDL cholesterol, along with other lipid markers, provides essential information about your cardiovascular health. Since VLDL is calculated from your triglyceride levels, comprehensive lipid testing gives you the full picture of your cholesterol profile.

When to get tested

The American Heart Association recommends that adults aged 20 or older have their cholesterol checked every 4-6 years if they're at low risk. However, more frequent testing may be necessary if you have risk factors such as family history of heart disease, diabetes, obesity, or if you're making lifestyle changes to improve your cholesterol levels.

Understanding your complete lipid panel

A complete lipid panel includes total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and calculated VLDL. Advanced testing may also include apolipoprotein B (ApoB), which measures the number of atherogenic particles in your blood and provides additional insight into cardiovascular risk beyond standard cholesterol measurements.

Strategies to lower VLDL cholesterol

Reducing elevated VLDL levels requires a comprehensive approach targeting the underlying causes. Since VLDL is closely tied to triglyceride levels, strategies that lower triglycerides typically reduce VLDL as well.

Dietary modifications

  • Reduce refined carbohydrates and added sugars, aiming for less than 10% of daily calories from added sugars
  • Increase omega-3 fatty acids from fish, walnuts, and flaxseeds, which can lower triglyceride production
  • Choose complex carbohydrates with fiber, such as whole grains, legumes, and vegetables
  • Limit alcohol intake, as even moderate consumption can raise triglycerides in sensitive individuals
  • Replace saturated fats with unsaturated fats from olive oil, avocados, and nuts

Exercise and weight management

Regular physical activity is one of the most effective ways to lower VLDL cholesterol. Aim for at least 150 minutes of moderate-intensity aerobic exercise weekly, such as brisk walking, swimming, or cycling. Resistance training twice weekly provides additional benefits for lipid metabolism.

Even modest weight loss of 5-10% of body weight can significantly reduce VLDL levels, particularly if you carry excess weight around your midsection. Combining dietary changes with increased physical activity creates a synergistic effect for improving your lipid profile.

Medical interventions

When lifestyle modifications aren't sufficient, medications may be necessary. Statins, while primarily targeting LDL cholesterol, can also reduce VLDL levels by 10-20%. Fibrates specifically target triglyceride reduction and can lower VLDL by 20-50%. Omega-3 fatty acid supplements at prescription doses (2-4 grams daily) can reduce triglycerides by 20-30%.

Newer medications like PCSK9 inhibitors may also help in certain cases, particularly for individuals with genetic lipid disorders. Your healthcare provider can determine the most appropriate treatment based on your overall cardiovascular risk profile and response to lifestyle changes.

Taking control of your cardiovascular health

High VLDL cholesterol significantly impacts your heart health by contributing to atherosclerosis, increasing inflammation, and elevating your risk of heart attacks and strokes. While genetic factors play a role, many causes of elevated VLDL are modifiable through targeted lifestyle changes.

Regular monitoring of your lipid levels, including VLDL cholesterol, provides valuable insights into your cardiovascular risk and helps track the effectiveness of your interventions. By combining dietary modifications, regular exercise, weight management, and medical treatment when necessary, you can effectively lower your VLDL levels and protect your heart health for years to come.

Remember that improving your VLDL cholesterol is a gradual process that requires consistency and patience. Small, sustainable changes often yield better long-term results than drastic short-term measures. Work with your healthcare provider to develop a personalized plan that addresses your specific risk factors and health goals.

References

  1. Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. The Lancet, 384(9943), 626-635.[Link][DOI]
  2. Ference, B. A., et al. (2019). Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease. JAMA, 321(4), 364-373.[Link][PubMed][DOI]
  3. Packard, C. J., & Shepherd, J. (2020). Lipoprotein heterogeneity and apolipoprotein B metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(12), 3542-3556.[PubMed]
  4. Miller, M., et al. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 123(20), 2292-2333.[Link][PubMed][DOI]
  5. Ginsberg, H. N., et al. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies. European Heart Journal, 42(47), 4791-4806.[Link][PubMed][DOI]
  6. Berglund, L., et al. (2012). Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 97(9), 2969-2989.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL at home?

You can test your VLDL at home with SiPhox Health's Heart & Metabolic Program, which includes VLDL testing along with comprehensive cardiovascular biomarkers. The program provides CLIA-certified lab results from a simple at-home blood draw.

What is the difference between VLDL and LDL cholesterol?

VLDL (very low-density lipoprotein) primarily carries triglycerides and contains 50-65% triglycerides by weight, while LDL (low-density lipoprotein) mainly carries cholesterol. VLDL particles are larger and eventually convert to LDL as they deliver triglycerides to tissues. Both contribute to heart disease risk, but through slightly different mechanisms.

Can VLDL levels change quickly with lifestyle modifications?

Yes, VLDL levels can respond relatively quickly to lifestyle changes since they're closely tied to triglyceride levels. Many people see improvements within 2-4 weeks of dietary modifications, though optimal results typically occur after 3-6 months of consistent healthy habits including diet, exercise, and weight management.

What foods should I avoid if I have high VLDL?

To lower VLDL, avoid or limit refined carbohydrates, sugary beverages, foods with high-fructose corn syrup, excessive alcohol, trans fats, and foods high in saturated fats. Focus instead on whole grains, lean proteins, fatty fish, vegetables, and foods rich in fiber and omega-3 fatty acids.

Is high VLDL genetic?

While genetic factors can influence VLDL levels through conditions like familial hypertriglyceridemia, most cases of elevated VLDL result from lifestyle factors such as diet, physical inactivity, and excess weight. Even with genetic predisposition, lifestyle modifications can significantly improve VLDL levels.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details